Bristol-Myers Squibb
BMY
BMY
2,133 hedge funds and large institutions have $63.6B invested in Bristol-Myers Squibb in 2024 Q2 according to their latest regulatory filings, with 169 funds opening new positions, 683 increasing their positions, 1,042 reducing their positions, and 320 closing their positions.
New
Increased
Maintained
Reduced
Closed
less call options, than puts
Call options by funds: $ | Put options by funds: $
less ownership
Funds ownership: →
less funds holding
Funds holding: →
less funds holding in top 10
Funds holding in top 10: →
24% less capital invested
Capital invested by funds: $84.2B → $63.6B (-$20.6B)
34% less repeat investments, than reductions
Existing positions increased: 683 | Existing positions reduced: 1,042
47% less first-time investments, than exits
New positions opened: 169 | Existing positions closed: 320
Holders
2,133
Holding in Top 10
18
Calls
$1.5B
Puts
$1.65B
Top Buyers
| 1 | +$443M | |
| 2 | +$222M | |
| 3 | +$161M | |
| 4 |
Federated Hermes
Pittsburgh,
Pennsylvania
|
+$145M |
| 5 |
Squarepoint
New York
|
+$143M |
Top Sellers
| 1 | -$615M | |
| 2 | -$589M | |
| 3 | -$291M | |
| 4 |
Franklin Resources
San Mateo,
California
|
-$241M |
| 5 |
N
Nuveen
Charlotte,
North Carolina
|
-$183M |